Alecnib 150 mg (Alectinib) Capsules

Alecnib (Alectinib) is a targeted cancer therapy used mainly in the treatment of ALK-positive non-small cell lung cancer (NSCLC). It belongs to a class of medicines known as ALK inhibitors, which work by blocking abnormal proteins responsible for uncontrolled cancer cell growth.

✔ Therapeutic Effects:

• Helps slow down or stop cancer cell growth
• Targets ALK gene mutation specifically
• Reduces tumor size in lung cancer patients
• Helps prevent cancer progression to other organs such as the brain
• Improves survival rate in ALK-positive NSCLC patients

This medicine is usually prescribed when the cancer has advanced or has spread beyond the lungs, or when previous treatments are not effective.

Each hard capsule contains:

• Alectinib Hydrochloride INN
• Equivalent to Alectinib 150 mg

Other excipients may include:

• Capsule shell components
• Stabilizing agents
• Pharmaceutical-grade inactive ingredients for proper absorption and stability

✔ Standard Adult Dose:

• Typical dose: 600 mg twice daily (as prescribed by physician)
• Usually taken as multiple 150 mg capsules per dose

✔ How to Take:

• Take capsules orally with food
• Swallow whole with water
• Do not crush or open capsules

✔ Missed Dose:

• If a dose is missed, take it as soon as remembered
• Skip if next dose time is near
• Never double dose

✔ Important Instructions:

• Take at the same time every day
• Follow oncologist’s exact prescription
• Regular monitoring required during treatment
• Do not stop without medical advice